Anti-Human IL20 Recombinant Antibody (Fletikumab) (CAT#: TAB-H34)
Recombinant human antibody to Human IL20
Specific Inquiry
Normal Tissue
RNA Expression
Figure 1 IHC staining of human stomach
(Immunohistochemical staining of human stomach shows strong cytoplasmic positivity in parietal cells.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/ihc_selected.jpg
(Immunohistochemical staining of human stomach shows strong cytoplasmic positivity in parietal cells.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/ihc_selected.jpg
Figure 2 Cerebral cortex
(Glial cells Staining: Low Intensity: Moderate Quantity: <25% Location: Cytoplasmic/ membranous Neuronal cells Staining: Low Intensity: Moderate Quantity: <25% Location: Cytoplasmic/ membranous Neuropil Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/57430_B_7_5.jpg
(Glial cells Staining: Low Intensity: Moderate Quantity: <25% Location: Cytoplasmic/ membranous Neuronal cells Staining: Low Intensity: Moderate Quantity: <25% Location: Cytoplasmic/ membranous Neuropil Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/57430_B_7_5.jpg
Figure 3 Colon
(Glandular cells Staining: Medium Intensity: Moderate Quantity: 75%-25% Location: Cytoplasmic/ membranous Peripheral nerve/ganglion Staining: Low Intensity: Weak Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/57430_A_9_3.jpg
(Glandular cells Staining: Medium Intensity: Moderate Quantity: 75%-25% Location: Cytoplasmic/ membranous Peripheral nerve/ganglion Staining: Low Intensity: Weak Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/57430_A_9_3.jpg
Figure 4 Liver
(Cholangiocytes Staining: Not detected Intensity: Weak Quantity: <25% Location: Cytoplasmic/ membranous Hepatocytes Staining: Low Intensity: Weak Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/57430_A_7_4.jpg
(Cholangiocytes Staining: Not detected Intensity: Weak Quantity: <25% Location: Cytoplasmic/ membranous Hepatocytes Staining: Low Intensity: Weak Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/57430_A_7_4.jpg
Figure 5 Kidney
(Cells in tubules Staining: Medium Intensity: Strong Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/57430_A_7_5.jpg
(Cells in tubules Staining: Medium Intensity: Strong Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/25802/57430_A_7_5.jpg
Figure 6 RNA cell line category: Cell line enhanced (SiHa)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000162891-IL20
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000162891-IL20
Specifications
- Host Species
- human
- Derivation
- human
- Type
- IgG4 - kappa
- Specificity
- IL20 (interleukin 20, IL-20) [Homo sapiens]
- Species Reactivity
- Human
- Applications
- Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.
- CAS
- 1357158-22-5
- Generic Name
- fletikumab
- ChEMBL
- CHEMBL3301580
- MW
- 146.5 kDa
- Related Disease
- Rheumatoid arthritis (RA)
Product Property
- Purity
- >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Target
- Alternative Names
- fletikumab;1357158-22-5;NNC0109-0012;NN8226;IL20;interleukin 20;interleukin-20;IL 20;IL10D;ZCYTO10;cytokine Zcyto10;four alpha helix cytokine;IL-20;MGC96907;
- Gene ID
- 50604
- UniProt ID
- Q9NYY1
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Fletikumab"
Afuco™ Anti-IL20 ADCC Recombinant Antibody (Fletikumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human IL20
See other products for "IL20"
Humanized Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0009CL | Human Anti-IL20 Recombinant Antibody (TAB-0009CL) | Inhib, IB, FC, RIA | Humanized Antibody |
| TAB-0009CL-S(P) | Human Anti-IL20 Recombinant Antibody; scFv Fragment (TAB-0009CL-S(P)) | Inhib, ELISA, SPR | Humanized scFv |
| TAB-0009CL-F(E) | Human Anti-IL20 Recombinant Antibody; Fab Fragment (TAB-0009CL-F(E)) | Inhib, ELISA, SPR | Humanized Fab |
| TAB-565LC | Anti-human IL20 Recombinant Antibody (FLB5M5) (TAB-565LC) | ELISA, Inhib, FuncS | Humanized antibody |
| TAB-565LC-S(P) | Anti-human IL20 scFv Fragment (FLB5M5) | ELISA | Humanized antibody |
Mouse Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-560LC | Rat Anti-IL20 Recombinant Antibody (TAB-560LC) | ELISA | Rat IgG |
| TAB-560LC-S(P) | Rat Anti-IL20 Recombinant Antibody; scFv Fragment (TAB-560LC-S(P)) | ELISA | Rat scFv |
| TAB-560LC-F(E) | Rat Anti-IL20 Recombinant Antibody; Fab Fragment (TAB-560LC-F(E)) | ELISA | Rat Fab |
Human Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-561LC-S(P) | Anti-human IL20 scFv Fragment (20A10) | ELISA | Human antibody |
| TAB-561LC-F(E) | Anti-human IL20 Fab Fragment (20A10) | ELISA | Human antibody |
| TAB-562LC-F(E) | Anti-human IL20 Fab Fragment (2A11) | ELISA | Human antibody |
| TAB-563LC-F(E) | Anti-human IL20 Fab Fragment (7D1) | ELISA | Human antibody |
| TAB-564LC-F(E) | Anti-human IL20 Fab Fragment (6E11) | ELISA | Human antibody |
Recombinant Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-0963CT | Recombinant Mouse anti-Human IL20 Monoclonal antibody (EML1475) | WB | |
| HPAB-0008-LS | Human Anti-IL20 Recombinant Antibody (HPAB-0008-LS) | Inhib | Humanized lgG |
| HPAB-0723-CN | Human Anti-IL20 Recombinant Antibody (clone 15D2) | WB, ELISA, FC, IHC | Human IgG4, κ |
| HPAB-0724-CN | Human Anti-IL20 Recombinant Antibody (clone 5B7) | WB, FC, IHC | Human IgG4, κ |
| HPAB-0069-WJ | Human Anti-IL20 Recombinant Antibody (HPAB-0069-WJ) | WB, FC, IHC | Human IgG |
Neutralizing Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| NEUT-1324CQ | Rat Anti-Il20 Recombinant Antibody (clone CBL626) | Neut | Rat IgG2b |
Rabbit Monoclonal Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOR-4256 | Rabbit Anti-IL20 Recombinant Antibody (clone SI336DS) | ELISA | Rabbit IgG |
Fab Fragment Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-0008-LS-F(E) | Human Anti-IL20 Recombinant Antibody; Fab Fragment (HPAB-0008-LS-F(E)) | Inhib | Humanized Fab |
| HPAB-0009-LS-F(E) | Human Anti-IL20 Recombinant Antibody; Fab Fragment (HPAB-0009-LS-F(E)) | Inhib | Humanized Fab |
| HPAB-0723-CN-F(E) | Human Anti-IL20 Recombinant Antibody (clone 15D2); Fab Fragment | WB, ELISA, Neut | Human Fab |
| HPAB-0724-CN-F(E) | Human Anti-IL20 Recombinant Antibody (clone 5B7); Fab Fragment | WB, ELISA, Neut | Human Fab |
| HPAB-0069-WJ-F(E) | Human Anti-IL20 Recombinant Antibody; Fab Fragment (HPAB-0069-WJ-F(E)) | IHC, ELISA, WB | Human Fab |
scFv Fragment Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-0008-LS-S(P) | Human Anti-IL20 Recombinant Antibody; scFv Fragment (HPAB-0008-LS-S(P)) | Inhib | Humanized scFv |
| HPAB-0009-LS-S(P) | Human Anti-IL20 Recombinant Antibody; scFv Fragment (HPAB-0009-LS-S(P)) | Inhib | Humanized scFv |
| HPAB-0723-CN-S(P) | Human Anti-IL20 Recombinant Antibody (clone 15D2); scFv Fragment | WB, ELISA, Neut | Human scFv |
| HPAB-0724-CN-S(P) | Human Anti-IL20 Recombinant Antibody (clone 5B7); scFv Fragment | WB, ELISA, Neut | Human scFv |
| HPAB-0069-WJ-S(P) | Human Anti-IL20 Recombinant Antibody; scFv Fragment (HPAB-0069-WJ-S(P)) | IHC, ELISA, WB | Human scFv |
ADCC Enhanced Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| AFC-TAB-H34 | Afuco™ Anti-IL20 ADCC Recombinant Antibody (Fletikumab), ADCC Enhanced | IF, IP, Neut, FuncS, ELISA, FC | ADCC enhanced antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-H34. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.